258 related articles for article (PubMed ID: 21389115)
1. Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.
Chang KH; Multani PS; Sun KH; Vincent F; de Pablo Y; Ghosh S; Gupta R; Lee HP; Lee HG; Smith MA; Shah K
Mol Biol Cell; 2011 May; 22(9):1452-62. PubMed ID: 21389115
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.
Sun KH; Lee HG; Smith MA; Shah K
Mol Biol Cell; 2009 Nov; 20(21):4611-9. PubMed ID: 19776350
[TBL] [Abstract][Full Text] [Related]
3. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.
Chang KH; de Pablo Y; Lee HP; Lee HG; Smith MA; Shah K
J Neurochem; 2010 Jun; 113(5):1221-9. PubMed ID: 20345761
[TBL] [Abstract][Full Text] [Related]
4. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
Shi C; Viccaro K; Lee HG; Shah K
J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
6. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
7. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
8. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
Chang KH; Vincent F; Shah K
J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
10. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH
J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.
Alvarez A; Toro R; Cáceres A; Maccioni RB
FEBS Lett; 1999 Oct; 459(3):421-6. PubMed ID: 10526177
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
13. Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron.
Chao AC; Chen CH; Wu MH; Hou BY; Yang DI
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118628. PubMed ID: 31884068
[TBL] [Abstract][Full Text] [Related]
14. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Shukla V; Skuntz S; Pant HC
Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
[TBL] [Abstract][Full Text] [Related]
15. Unveiling Potential Neurotoxic Mechansisms: Pb-Induced Activation of CDK5-p25 Signaling Axis in Alzheimer's Disease Development, Emphasizing CDK5 Inhibition and Formation of Toxic p25 Species.
Lokesh M; Bandaru LJM; Rajanna A; Rao JS; Challa S
Mol Neurobiol; 2024 May; 61(5):3090-3103. PubMed ID: 37968421
[TBL] [Abstract][Full Text] [Related]
16. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.
Nikhil K; Shah K
J Cell Sci; 2017 Sep; 130(18):3023-3039. PubMed ID: 28751497
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
[TBL] [Abstract][Full Text] [Related]
18. Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice.
Huang Y; Huang W; Huang Y; Song P; Zhang M; Zhang HT; Pan S; Hu Y
J Alzheimers Dis; 2020; 74(4):1231-1242. PubMed ID: 32144987
[TBL] [Abstract][Full Text] [Related]
19. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]